UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

Protein Therapeutics

1st, 2017

Volltextzugriff (PDF)

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer

PLoS genetics, 2016-04, Vol.12 (4), p.e1005895-e1005895

2016

Volltextzugriff (PDF)

Developing innovative targeted therapies for China

Journal of translational medicine, 2012-10, Vol.10 (S2), p.A3-A3, Article A3

Jallal, Bahija

2012

Volltextzugriff (PDF)

MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis

Nature communications, 2015-05, Vol.6 (1), p.7096-7096, Article 7096

2015

Volltextzugriff (PDF)

Targeting the Insulin-like Growth Factor Axis for the Development of Novel Therapeutics in Oncology

Cancer research (Chicago, Ill.), 2012, Vol.72 (1), p.3-12

2012

Volltextzugriff (PDF)

TRAF6-Dependent Act1 Phosphorylation by the IκB Kinase-Related Kinases Suppresses Interleukin-17-Induced NF-κB Activation

Molecular and Cellular Biology, 2012-10, Vol.32 (19), p.3925-3937

2012

Volltextzugriff (PDF)

In Vivo Therapeutic Success of MicroRNA‐155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.953-964

2016

Volltextzugriff (PDF)

Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies

Arthritis & rheumatology (Hoboken, N.J.), 2014-04, Vol.66 (4), p.1022-1033

2014

Volltextzugriff (PDF)

Type I interferon: potential therapeutic target for psoriasis?

PloS one, 2008-07, Vol.3 (7), p.e2737-e2737

2008

Volltextzugriff (PDF)

Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth

Cancer research (Chicago, Ill.), 2011-02, Vol.71 (3), p.1029-1040

2011

Volltextzugriff (PDF)

MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D

Pigment cell and melanoma research, 2014-03, Vol.27 (2), p.275-286

2014

Volltextzugriff (PDF)

EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target

Cancer biology & therapy, 2012-06, Vol.13 (8), p.630-637

2012

Volltextzugriff (PDF)

PAK4 mediates morphological changes through the regulation of GEF-H1

Journal of cell science, 2005-05, Vol.118 (9), p.1861-1872

2005

Volltextzugriff (PDF)

Altered expression of insulin receptor isoforms in breast cancer

PloS one, 2011-10, Vol.6 (10), p.e26177-e26177

2011

Volltextzugriff (PDF)

Requirement for PAK4 in the Anchorage-independent Growth of Human Cancer Cell Lines

The Journal of biological chemistry, 2002-01, Vol.277 (1), p.550-558

2002

Volltextzugriff (PDF)

Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles

Muscle & nerve, 2010-10, Vol.42 (4), p.576-583

2010

Volltextzugriff (PDF)

Bahija Jallal

Nature reviews. Drug discovery, 2019-03

2019

Volltextzugriff (PDF)

The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells

Blood, 2008-08, Vol.112 (3), p.711-720

2008

Volltextzugriff (PDF)

A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children

Vaccine, 2010-04, Vol.28 (16), p.2865-2876

2010

Volltextzugriff (PDF)

Genomic signatures characterize leukocyte infiltration in myositis muscles

BMC medical genomics, 2012-11, Vol.5 (1), p.53-53, Article 53

2012

Volltextzugriff (PDF)

Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2–positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib

Molecular cancer therapeutics, 2009-08, Vol.8 (8), p.2131-2141

2009

Volltextzugriff (PDF)

The Serine/Threonine Kinase Nek6 Is Required for Cell Cycle Progression through Mitosis

The Journal of biological chemistry, 2003-12, Vol.278 (52), p.52454-52460

2003

Volltextzugriff (PDF)

Genomic Biomarkers for Pharmaceutical Development: Advancing Personalized Health Care

Yihong Yao, Bahija Jallal, Koustubh Ranade

1, 2013

Volltextzugriff (PDF)

CHIR-258 Is Efficacious in A Newly Developed Fibroblast Growth Factor Receptor 3–Expressing Orthotopic Multiple Myeloma Model in Mice

Clinical cancer research, 2006-08, Vol.12 (16), p.4908-4915

2006

Volltextzugriff (PDF)

The STE20 Kinase HGK Is Broadly Expressed in Human Tumor Cells and Can Modulate Cellular Transformation, Invasion, and Adhesion

Molecular and Cellular Biology, 2003-03, Vol.23 (6), p.2068-2082

2003

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Englisch
(138)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Humans
(57)
Life Sciences & Biomedicine
(57)
Animals
(29)
Biological And Medical Sciences
(27)
Mice
(24)
Medical Sciences
(20)
Female
(18)
Adult
(15)
Oncology
(15)
Rheumatology
(15)
Gene Expression
(14)
Male
(14)
Antibodies, Monoclonal - Pharmacology
(13)
Biochemistry & Molecular Biology
(13)
Dna
(13)
Molecular Sequence Data
(13)
Cell Biology
(12)
Cell Line
(12)
Pharmacology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Protein Therapeutics

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer

Developing innovative targeted therapies for China

MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis

Targeting the Insulin-like Growth Factor Axis for the Development of Novel Therapeutics in Oncology

TRAF6-Dependent Act1 Phosphorylation by the IκB Kinase-Related Kinases Suppresses Interleukin-17-Induced NF-κB Activation

In Vivo Therapeutic Success of MicroRNA‐155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage

Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies

Type I interferon: potential therapeutic target for psoriasis?

Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth

MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D

EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target

PAK4 mediates morphological changes through the regulation of GEF-H1

Altered expression of insulin receptor isoforms in breast cancer

Requirement for PAK4 in the Anchorage-independent Growth of Human Cancer Cell Lines

Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles

Bahija Jallal

The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells

A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children

Genomic signatures characterize leukocyte infiltration in myositis muscles

Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2–positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib

The Serine/Threonine Kinase Nek6 Is Required for Cell Cycle Progression through Mitosis

Genomic Biomarkers for Pharmaceutical Development: Advancing Personalized Health Care

CHIR-258 Is Efficacious in A Newly Developed Fibroblast Growth Factor Receptor 3–Expressing Orthotopic Multiple Myeloma Model in Mice

The STE20 Kinase HGK Is Broadly Expressed in Human Tumor Cells and Can Modulate Cellular Transformation, Invasion, and Adhesion

Suchergebnisse filtern